Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system – the Stavanger experience

OBJECTIVE: To describe early experience of replacing PSA with Stockholm3 for detection of prostate cancer in primary care. DESIGN AND METHODS: Longitudinal observations, comparing outcome measures before and after the implementation of Stockholm3. SETTING: Stavanger region in Norway with about 370,0...

Descripción completa

Detalles Bibliográficos
Autores principales: Viste, Eirik, Vinje, Cathrine Alvaer, Lid, Torgeir Gilje, Skeie, Svein, Evjen-Olsen, Øystein, Nordström, Tobias, Thorsen, Olav, Gilje, Bjørnar, Janssen, Emiel A. M., Kjosavik, Svein R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470071/
https://www.ncbi.nlm.nih.gov/pubmed/32772613
http://dx.doi.org/10.1080/02813432.2020.1802139

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470071/
https://www.ncbi.nlm.nih.gov/pubmed/32772613
http://dx.doi.org/10.1080/02813432.2020.1802139

Ejemplares similares